Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity
Open Access
- 28 January 2026
- journal article
- Published by Wiley in Molecular Oncology
- Vol. 20 (5) , 1161-1184
Abstract
Peroxidasin (PXDN), an extracellular matrix (ECM)‐associated peroxidase, has been implicated in cancer progression. However, its roles in melanoma biology and therapeutic sensitivity remain unclear. Here, we demonstrate that elevated PXDN expression is associated with poor prognosis and reduced survival in melanoma patients. Functional studies revealed that PXDN depletion impairs melanoma cell proliferation, disrupts the cell cycle, and reduces melanoma cell invasive capacities. Furthermore, we found that secreted PXDN modulates anti‐melanoma immunity by enhancing melanoma resistance to natural killer (NK)‐cell‐mediated cytotoxicity. Structural modeling identified a trimeric organization of PXDN, stabilized by disulfide‐linked peroxidase domains. Molecular dynamics simulations identified a previously unknown inhibitory interaction between the PXDN N‐terminal leucine‐rich repeat domain and the NK cell‐activating receptor NKG2‐D type II integral membrane protein (NKG2D). These findings uncover a redox‐independent role for PXDN in promoting immune evasion and tumor progression. Overall, our study highlights PXDN as a critical regulator of melanoma cell biology and a potential therapeutic target for NK‐cell‐based immunotherapy in melanoma and other solid cancers.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (BO 3643/10‐1)
- Deutsche Forschungsgemeinschaft (CRC 1027)
- Deutsche Forschungsgemeinschaft (CRC 1190)
- Deutsche Forschungsgemeinschaft (GRK 2978)
- Studienstiftung des Deutschen Volkes
- Fonds Wetenschappelijk Onderzoek (1193522N)
- Fonds Wetenschappelijk Onderzoek (G028821N)
- Vrije Universiteit Brussel (IRP20)
- Vrije Universiteit Brussel (SRP34)
- Vlaams Instituut voor Biotechnologie
This publication has 76 references indexed in Scilit:
- Augmenting NK cell-based immunotherapy by targeting mitochondrial apoptosisCell, 2022
- The leucine-rich repeat domain of human peroxidasin 1 promotes binding to laminin in basement membranesArchives of Biochemistry and Biophysics, 2020
- Oxidative Stress in CancerCancer Cell, 2020
- Monomeric and homotrimeric solution structures of truncated human peroxidasin 1 variantsBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2020
- Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial DependenceCell, 2019
- High expression of PXDN is associated with poor prognosis and promotes proliferation, invasion as well as migration in ovarian cancerAnnals of Diagnostic Pathology, 2018
- Small molecule inhibitors of mammalian thioredoxin reductase as potential anticancer agents: An updateMedicinal Research Reviews, 2018
- Overcoming Intrinsic Multidrug Resistance in Melanoma by Blocking the Mitochondrial Respiratory Chain of Slow-Cycling JARID1Bhigh CellsCancer Cell, 2013
- Oncogenic BRAF Regulates Oxidative Metabolism via PGC1α and MITFCancer Cell, 2013
- Exploring protein native states and large‐scale conformational changes with a modified generalized born modelProteins: Structure, Function, and Bioinformatics, 2004